Japan says yes to Boston's DES (drug-eluting stent):
This article was originally published in Clinica
Executive Summary
Boston Scientific has gained the all-clear to take its drug-eluting stent DESs to the Japanese market. Its Taxus Express2 paclitaxel-eluting coronary stent was approved by the country's Ministry of Health, Labor and Welfare (MHLW), and Boston plans to launch the product after reimbursement clearance is granted. Japan approved its first DES in 2004 - Johnson & Johnson's sirolimus-eluting stent, Cypher.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.